On September 8, 2023, Edward Jordan informed Humanigen, Inc. of his resignation from his position as Chief Commercial Officer of the Company, effective September 14, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +50.00% | +50.00% | -75.00% |
Apr. 12 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
Mar. 08 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-75.00% | 23.82K | |
-1.64% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Announces Resignation of Edward Jordan as Chief Commercial Officer